African Masks FRANCO MONTI

Autor: Novaes, Sylvia M. Caiuby

Publikováno v: Revista de Antropologia, 1969 Jan 01. 17/20(2), 360-361.

Externí odkaz: https://www.jstor.org/stable/41615883

Detection of Colorectal Cancer by a Quantitative Fluorescence Determination of DNA Amplification in Stool

Autor: Daniele Calistri, Claudia Rengucci, Arturo Lattuneddu, Gianfranco Francioni, Anna Maria Polifemo, Oriana Nanni, Luca Saragoni, Franco Monti, Alberto Ravaioli, Wainer Zoli, Dino Amadori

Publikováno v: Neoplasia: An International Journal for Oncology Research, Vol 6, Iss 5, Pp 536-540 (2004)

DNA amplification of exfoliated cells in stool repre sents an inexpensive and rapid test, but has only 50% to 60% sensitivity. A new quantitative method, calle( fluorescence long DNA, was developed and validate( in our laboratory on stool obtained fr

Externí odkaz: https://doaj.org/article/1d564c6dc0514a3bb68076af2d6e0586

Il monitoraggio meno frequente dei linfociti CD4+ nei pazienti HIV+ in trattamento antiretrovirale non aumenta il rischio di patologie AIDS defining

Autor: Evita Massari, Andrea Boschi, Paolo Bassi, Massimo Arlotti, Romolo M. Dorizzi, Marta Monti, Luca Baldrati, Franco Monti, Marco Rosetti

Publikováno v: La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine. 14:145-148

Il conteggio assoluto dei linfociti CD4+, un indicatore importante dello stato immunitario, e utile nel monitoraggio dei pazienti con infezione da HIV ed e stato utilizzato per molti anni come criterio decisionale per l’inizio della terapia. La con

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::42aa79e5f40acd066e94febcf0b298f2
https://doi.org/10.1007/s13631-018-0187-9

Potential of telomerase expression and activity in cervical specimens as a diagnostic tool

Autor: Sara Bravaccini, Daniele Calistri, Maria Aurora Sanchini, Amadori A, L. Saragoni, Dino Amadori, Franco Monti, Laura Medri, Annalisa Volpi

Publikováno v: Journal of Clinical Pathology. 58:911-914

Aims: To evaluate the potential use of the immunohistochemical expression of telomerase and the measurement of its activity as diagnostic tools in the uterine cervix. Methods: The fluorescent telomeric repeat amplification protocol (TRAP) assay was u

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d53b9f649a42636601cafb1f41ee1bf
https://doi.org/10.1136/jcp.2004.024158

Pathology of ovarian cancers in BRCA1 and BRCA2 carriers

Autor: Robert Winqvist, Jan G. M. Klijn, Lesley McGuffog, Barbara L. Weber, Paul D.P. Pharoah, Dominique Stoppa Lyonet, Hanne Meijers-Heijboer, D. Timothy Bishop, Heli Nevanlinna, Gilbert M. Lenoir, Dawn Steele, Hagay Sobol, Yves-Jean Bignon, Samantha Merrett, Laurent Arnout, Bruce A.J. Ponder, Douglas F. Easton, Fernando Schmitt, Sunil R. Lakhani, Franco Monti, Peter Devilee, Sanjiv Manek, Frédérique Penault-Llorca, Susan L. Neuhausen, Jocylyne Jacquemier, Adrienne M. Flanagan, Geoff Lane, Teresa Wagner, Ralf Bützow, Paolo Radice, Silvana Pilotti, Susanne Seitz, Ute Hamman

Publikováno v: Clinical Cancer Research, 10, 2473-2481. American Association for Cancer Research Inc.
Clinical cancer research, 10(7), 2473-2481. American Association for Cancer Research Inc.

Purpose: Germline mutations in the BRCA1 and BRCA2 genes confer increased susceptibility to ovarian cancer. There is evidence that tumors in carriers may exhibit a distinct distribution of pathological features, but previous studies on the pathology

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc8c0c5c7e41201a59e80d44680da517
https://doi.org/10.1158/1078-0432.CCR-1029-3